Login with your work email address to view charts. No credit card required.
| Art Unit: | 3991 — Active solid-state devices (e.g., transistors, solid-state diodes) |
|---|---|
| Group: | 3990 — Central Reexamination Unit |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 435 — Chemistry: molecular biology and microbiology 506 — Combinatorial chemistry technology: method, library, apparatus 600 — Surgery 800 — Multicellular living organisms and unmodified parts thereof and related processes 544 — Organic compounds -- part of the class 532-570 series |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| 3-Year Grant rate: | 36% over 231 cases |
|---|---|
| Difficulty: | Very Hard |
| Difficulty Percentile: | 88th
|
With Examiner Orwig, you have a 36% chance of getting an issued patent by 3 years after the first office action. Examiner Orwig is a very hard examiner and in the 88th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Orwig, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Orwig's grant rate is lower than that of Art Unit 3991 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Orwig | 1.1 |
| Art Unit 3991 | 1.7 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.